Epstein syndrome (Q96603): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1379284603 / rank
 
Normal rank

Revision as of 12:37, 16 August 2026

Epstein syndrome is one form of the ``MYH9 syndrome'' (a group that includes four clinical forms with similar manifestations resulting from mutations in the MYH9 gene: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome), characterised by usually severe macrothrombocytopenia but paradoxically resulting in few if any symptoms. Macrothrombocytopenia is defined as the presence of giant platelets, with a diameter equal to or greater than that of a red blood cell. Epstein syndrome clinically resembles Fechtner syndrome (renal involvement marked by interstitial glomerulonephritis and sensorineural deafness associated with thrombopenia), but it can be distinguished by the absence of cataract.
Language Label Description Also known as
default for all languages
ID_1379284603
    English
    Epstein syndrome
    Epstein syndrome is one form of the ``MYH9 syndrome'' (a group that includes four clinical forms with similar manifestations resulting from mutations in the MYH9 gene: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome), characterised by usually severe macrothrombocytopenia but paradoxically resulting in few if any symptoms. Macrothrombocytopenia is defined as the presence of giant platelets, with a diameter equal to or greater than that of a red blood cell. Epstein syndrome clinically resembles Fechtner syndrome (renal involvement marked by interstitial glomerulonephritis and sensorineural deafness associated with thrombopenia), but it can be distinguished by the absence of cataract.

      Statements